Northeast Endocrine Metabolic Associates

Philadelphia, Pennsylvania 19114-1028

2 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type 2, Kidney Disease, Chronic, Obesity, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Recruiting now
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed